# Resistomap

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/resistomap

- Industry: Biotechnology
- Headquarters: Helsinki, Finland
- Website: www.resistomap.com
- Total disclosed funding: $2M
- Latest round: Seed (Nov 15, 2023)
- Investors on record: 3

## About

Founded in 2018 and based in Helsinki, Finland, Resistomap Oy operates as a provider of a Finnish platform that provides robust monitoring tools to combat the spread of antibiotic resistance in the environment. The company was founded by a microbiologist Dr. Windi Muziasar, and a data scientist William Nurmi, who serve as CEO and CTO respectively in the company. The company was supported by Nordic Laboratories’ state-of-the-art facilities when it started. In November 2023, Resistomap Oy raised USD 2 million in seed funding co-led by new investors Ananda Impact Ventures and Gaingels, with participation from new investor Business Finland.

The company offers antibiotic resistance services specializing in various fields including aquaculture, agriculture, hospital, water research, wildlife, and WWTP (wastewater treatment plans).

The company will use the funding raised in 2023  November to develop and expand a global biosecurity intelligence platform for antimicrobial resistance.

## Funding rounds

- Seed, Nov 15, 2023, $2M — Business Finland Venture Capital, Ananda Impact Ventures, Gaingels

## Investors

- Business Finland Venture Capital — Seed
- Ananda Impact Ventures (https://capitalatlas.ai/funds/ananda-impact-ventures) — Seed
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Seed